Controversial Issues Related to Coding and Billing for Carotid Interventions Roseanne R. Wholey 2010.

Slides:



Advertisements
Similar presentations
HCA Session III Teaching Physician Rules Time Based Coding; Counseling
Advertisements

Medical Billing Compliance Clinical Trial Billing Audits at Yale: Processes and Findings November 10, 2011.
Medicare Transmittal 956 CR 5124 May 19, 2006 NOPR Billing Instruction Clarification – Physician Offices/IDTF use QR Modifier – Hospitals use QR and V70.7.
Clinical Trials: Clinical Research Billing, MSP, MMSEA, and Other Issues Meant to Complicate Our Lives 2011 Corporate Council Meeting 17 February 2011.
Inpatient Coding Strategies American College of Physicians March 1, 2013.
5/11/20151 ALL YOU EVER WANTED TO KNOW ABOUT BILLING & REIMBURSEMENT BUT WERE AFRAID TO ASK Presented by: Evelyn Alwine, RHIA CHDA Director Revenue Cycle.
January 2014 Jean C. Russell, MS, RHIT Richard Cooley, BA, CCS
Coding Clinical Encounters. Definition of Terms: CPT E/M and Procedure Codes The CPT E/M section is divided into broad categories such as office visits,
Blood Product Reimbursement Report 4 th QuarterNovember 2009Volume 1, Number This information is provided as a service to assist hospitals and other.
Treatment of Hand Ischemia Dialysis Associated Steal Syndrome (DASS) ASDIN Coding University 1.
Treatment of Accessory Vein ASDIN Coding University 1.
Columbia University Medical Center Research Billing Compliance presented by Office for Billing Compliance Research Billing Compliance presented by Office.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Medicare OT 232 Chapter 10 1OT 232 Chapter 10. Medicare Established?! – 1965 Managed by?! – CMS under… – DHHS Eligible beneficiaries – 65+ – Disabled.
Lower Extremity Revascularization Coding and its Relationship to Vascular Access Procedures ASDIN Coding University 1.
INTRODUCTION TO ICD-9-CM
February 2014 Jean C. Russell, MS, RHIT Richard Cooley, BA, CCS
Copyright © 2008 Delmar Learning. All rights reserved. Chapter 9 CMS Reimbursement Methodologies.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
John E. Steiner, Jr., Esq Chief Compliance Officer Cleveland Clinic Health System Cleveland, Ohio Coverage and Billing Issues for Clinical Research The.
Angioplasty Coding ASDIN Coding University 1 Angioplasty Coding Angioplasty may be venous or arterial; these have different codes and special rules that.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Reimbursement Nutr 564: Summer Objectives n Identify the components of reimbursement n Describe the barriers n Identify resources for MNT reimbursement.
Credentials, Reporting and Billing Matthew J. Budoff, MD, FACC Associate Professor of Medicine Division of Cardiology Harbor-UCLA Medical Center, Torrance.
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
1 The Role of Medicare National Coverage in the Regulatory Process Steve Phurrough MD, MPA Director, Coverage and Analysis Group Centers for Medicare and.
Endovascular treatment on tandem lesions of cranial arteries Xiao-Long Zhang, MD, PhD Department of Radiology Huashan Hospital,Fudan University Shanghai.
Trial Design Issues Associated with Evaluation of Distal Protection Devices in Diseased Saphenous Vein Grafts Bram D. Zuckerman, MD, FACC Medical Officer,
Investigational Devices and Humanitarian Use Devices June 2007.
Copyright © 2016 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
Important Information
Ensures that studies are billed for research specific procedures.
CP CARE Registry Insights to the Future.
Understanding Policy Regulations and Reimbursement Practices Impacting Telehealth Programs Rena Brewer, RN, MA CEO, Global Partnership for Telehealth Lloyd.
Cerebral Angiography Radiological study of the blood vessels of the brain to enable physicians to localized and diagnose pathology or anomalies of the.
CAROTID ARTERY ENDARTHERECTOMY &INTERVENTION
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Reimbursement Nutr 564: Summer Objectives n Identify the components of reimbursement n Describe the barriers n Identify resources for MNT reimbursement.
Click to begin. Click here for Bonus round OIG Issues Medicare & Medicaid General 100 Point 200 Points 300 Points 400 Points 500 Points 100 Point 200.
Clinical Trial Billing and Patient Remuneration
HCPCS Level II National Coding System
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
The Placement of Stents Associated with Vascular Access
Clinical Terminology and One Touch Coding for EPIC or Other EHR
(p for noninferiority = 0.01)
Chapter 9 Medicare.
Collaborative Practice Agreements
The CARE Registry is a benchmarking tool for health care providers to measure and improve the care they provide for patients undergoing Carotid Stent.
The Peer Review Higher Weighted Diagnosis-Related Groups
Why are the Government and Third Party Payors so Scared of CTA?
Complex Ostial Disease of the Aortic Arch Vessels
Advance Care Planning for FQHCs
Carotid Artery Stenting Predictors of procedural and clinical success
Category II & Category III
Diagnostic Medical Sonography Program
Bozeman Health Clinical Research
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
Introduction to Health Insurance
Learning About PET/CT Scans:
Medicare Updates January 2018.
Comprehensive Medical Assisting, 3rd Ed Unit Three: Managing the Finances in the Practice Chapter 15 – Outpatient Procedural Coding.
Anesthesia.
Comprehensive Medical Assisting, 3rd Ed Unit Three: Managing the Finances in the Practice Chapter 14 - Diagnostic Coding.
Medical Insurance Coding
Atlantic Cardiovascular Patient Outcomes Research Team
Observation vs Inpatient
Medical Necessity in the Outpatient Setting
Peripheral Vascular Intervention
Presentation transcript:

Controversial Issues Related to Coding and Billing for Carotid Interventions Roseanne R. Wholey 2010

Roseanne R. Wholey, MD DISCLOSURES I have no real or apparent conflicts of interest to report.

Carotid Stenting In the U.S. - slowed down due to the reluctance of insurance carriers to reimburse doctors who use them. For many years physicians performing these procedures were scrutinized by carriers with strict policy requirements.

Psalm 23 “Yea, though I walk through the valley of the shadow of death, I will fear no evil”

Who let the dogs out? FDA - Food and Drug Administration IRB - Institutional Review Board CMS - Centers for Medicare & Medicaid

History In the early 1980’s PTA for non-coronary vessels was generally accepted. There was no HCFA national non-coverage policy and as a result Medicare contractors had discretion in determining coverage for these procedures.

1984 The trouble begins In 1984, due to concerns of safety and efficacy, HCFA issued a NATIONAL NON-COVERAGE POLICY for PTA for the treatment of obstructive lesions of the aortic arch vessels.

They subsequently revised the policy that same year to cover obstructive lesions of a single coronary artery, the upper extremity (EXCLUDING HEAD AND NECK VESSELS), the renal artery and AV dialysis fistulas and grafts.

In 1995 HCFA issued regulations related to Medicare coverage of certain devices with an IDE approved by the FDA. For Category B devices HCFA permitted Medicare contractors to consider coverage on a local basis for Cat B devices with an IDE approved clinical trial protocol.

In 1997 HCFA expressed their belief that the non-coverage policy should continue but that a randomized clinical trial would be the best mechanism for compiling clinical data. It was decided that, due to the non-coverage status of the PTA, stents used during carotid PTA should not be covered.

In July 2000 President Clinton issued a memorandum to increase participation of Medicare beneficiaries in clinical trials and authorized Medicare payment for routine patient care costs and costs due to complications associated with participation in clinical trials. On 9-19-00 the Medicare Clinical Trials Policy went into effect.

A decision was made for Medicare to cover PTA of the carotid artery concurrent with stent placement when furnished in accordance with FDA approved protocols governing Category B IDE approved clinical trials, effective July 1, 2001.

2004 codes for physician services performed as part of a clinical trial Category III (emerging technology) Codes at that time were: 0005T Transcatheter placement extracranial cerebrovascular stent(s) initial (includes PTA procedure of the stented vessel & reported one time regardless of the number of stents placed in same ves’l) 0006T Each additional vessel 0007T S&I report separately each vessel

2004 reimbursement 0005T Initial stent $220.65 0006T Stent ea add’l ves’l $0 0007T S&I $ 45.26 No RV units assigned to tracking codes. Payment based on policies of payors and not a yearly fee schedule.

Vertebral/Cerebral PTA of vertebral and cerebral arteries was not covered

Embolic Protection There were no Category I codes to describe the use of embolic protection devices

FDA APPROVAL FOR CAROTID ARTERY STENTING On 8-31-04 the FDA granted approval for carotid artery stenting. This is the first approval the FDA has granted for CAS in the U.S. (for high risk patients who have had symptoms of a stroke or who have a carotid artery blockage of at least 80% and who are not good candidates for endarterectomy.)

On 12-17-04 CMS announced a proposed rule to provide coverage for CAS with DEP reversing their previous national non-coverage policy. But the decision did not immediately change the non-coverage policy and there are conditions to be met for coverage to be provided.

Medicare National Coverage Determination: Medicare limiting coverage to: High Risk symptomatic patients with carotid artery narrowing of 70% or more required use of approved CAS systems use of approved or cleared emb prot devices

Medicare will also cover patients who meet the FDA-labeled criteria for carotid stents, who are at high risk for carotid endarterectomy and have symptomatic carotid artery stenosis between 50-70% and asymptomatic carotid artery stenosis of 80% or more, in Category B IDE clinical trials, as a routine cost under the clinical trials policy, or in post-approval studies.

Diagnosis Requirement Claim data must include the diagnostic code 433.10, carotid stenosis or occlusion without infarct The determination that a patient is at high risk for CEA and the patient’s symptoms of carotid artery stenosis should be available in the patient medical record prior to performing any procedure

Inpatient requirement Carotid artery stenting is only covered as an inpatient service

Physician Services The previous Category III tracking codes for carotid stenting are no longer valid

2005 Category III codes for extracranial, vertebral or intrathoracic CAS Category III emerging technology codes: 0075T Transcatheter placement of extracranial, vertebral or intrathoracic carotid artery stent(s) including S&I percutaneous, initial vessel 0076T “ each additional vessel

2005 Category I CPT codes Codes released in November 2004 for implementation in 2005: 37215 Transcatheter placement of intravascular stent(s) cervical carotid artery, percutaneous w/distal protection 37216 “ without distal protection (as there will be times that distal protection cannot be successfully completed)

BUT... CMS dropped coverage for 37216 (w/o dp) The change was retroactive to 3-17-06 (the same day that CMS expanded national coverage which apparently restricted coverage to stents w/distal protection Carriers don’t have to retract payments already made - unless claims come to their attention

ABN If the pt would benefit by a carotid stent w/o distal protection you can offer an “advance beneficiary notice” explaining that the services are not covered and the patient is responsible for payment

2007 Medicare Reimbursement 37215 - $1,020.11 2008 Medicare Reimbursement 37215 - $914.31 2009 Medicare Reimbursement 37215 – $1077.96 2010 Medicare Reimbursement 37215 - $1137.90

Problem: 37215 = Bundled code If an ipsilateral angiogram confirms the need for CAS, code 37215 includes all ipsilateral selective carotid catheterization, all cervical and cerebral diagnostic imaging and S&I services

THERAPEUTIC INTERVENTION CATH Right common carotid cath DIAGNOSTIC IMAGING Unilateral carotid cervical Unilateral carotid cerebral THERAPEUTIC INTERVENTION Right carotid stenting w/embolic protection

CPT CODE: 37215

However... If a diagnostic study is performed and carotid stenting is not performed then the appropriate codes for carotid catheterization and imaging should be reported instead of code 37215

Interventional Component Coding allows for the separate coding of: Catheter Placement Radiologic imaging services Transcatheter Therapies Radiologic supervision and interpretation

In each vascular family the catheter placement is coded to the highest order branch UPPER EXTREMITY CODES: 36215 - First order upper extremity (ex: normal anatomy-left subclavian, left common carotid, innominate) 36216 - Second order (right subclavian, right common carotid, left internal, left external, left vertebral) 36217 - Third order (right vertebral, right internal, right external)

36218 - Each additional second or third order upper extremity catheter placement within a vascular family (list in addition to the code for the initial second or third order vessel as appropriate)

A non-selective catheter placement into the aorta would not be coded separately in addition to a selective catheter placement Selective catheter placement in different vascular families can be coded separately (modifier -59 is required by most payors to distinguish separate procedures)

Radiologic supervision and interpretation frequently used for carotid procedures: 75650 - Arch 75665 - Unilateral cerebral carotid 75671 - Bilateral cerebral carotids 75676 - Unilateral cervical carotids 75680 - Bilateral cervical carotids 75685 - Unilateral vertebral 75685 X 2 - Bilateral vertebrals

CATHS DIAGNOSTIC IMAGING Right and left common carotid arteries* Cervicocerebral arch Bilateral carotid cervical Bilateral carotid cerebral *do not use -50 bilateral modifier

CPT CODES/MODIFIERS PROCEDURE FEE SCHED/RED 2010 36216-RT Second order cath 283.40 283.40 36215-LT-59 First order cath 251.10 125.55 75680-26 Bilateral carotid cervical 83.96 83.96 75671-26 Bilateral carotid cerebral 83.24 83.24 75650-26 Cervicocerebral arch 74.81 74.81 ________ _______ TOTAL 776.51 650.96

CATHS DIAGNOSTIC IMAGING Right and left vertebral* Right and left common* DIAGNOSTIC IMAGING Bilateral carotid cervical Bilateral carotid cerebral Bilateral vertebral *do not use -50 bilateral modifier

CPT CODES/MODIFIERS PROCEDURE FEE SCHED/RED 2010 36217-RT Third order cath 335.75 335.75 36216-LT-59 Second order cath 283.40 141.70 36215-LT-59 First order cath 251.10 125.55 36218-RT Ea add 2nd/3rd order cath 53.55 53.55 75680-26 Bilateral carotid cervical 83.96 83.96 75671-26 Bilateral carotid cerebral 83.24 83.24 75685-26X2 Bilateral vertebral 66.36 66.36 66.36 66.36 ________ ________ TOTAL 1223.72 956.47

QUESTION Can you ever bill for both a diagnostic carotid procedure along with carotid artery stenting?

LT and Rt common carotid caths, bilateral cerebral and cervical a’gms, LT carotid stenting w/emb protection 37215-LT Stent w/distal protection 36216-RT 2nd order cath placement 75665-26 Unilateral cerebral a’gm 75676-26 Unilateral cervical a’gm

CPT CODES/MODIFIERS PROCEDURE FEE SCHED/RED 2010 37215LT Stent w/dist protection 1137.90 1137.90 36216RT Second order cath 283.40 141.70 75665-26 Unilat carotid cerebral 66.81 66.81 75676-26 Unilat carotid cervical 66.81 66.81 ________ ________ 1554.92 1413.22

Which would you choose? It is obvious!